首页> 外文期刊>Biomedical Statistics and Informatics >Application of Longitudinal Measured CD4+ Count on HIV-Positive Patients Following Active Antiretroviral Therapy: A Case of Debre Berhan Referral Hospital
【24h】

Application of Longitudinal Measured CD4+ Count on HIV-Positive Patients Following Active Antiretroviral Therapy: A Case of Debre Berhan Referral Hospital

机译:纵向测量的CD4 +计数在积极抗逆转录病毒治疗后的HIV阳性患者中的应用:Debre Berhan转诊医院的一例

获取原文
           

摘要

The measurement of the CD4+ count is the predictor of evolution to AIDS, in ART. Studying the way of the CD4+ count over time provides an insight to the disease evolution. The main objective of this study was to apply statistical analysis on longitudinally measured CD4+ Cell counts of HIV-positive patients under ART. The study population consists of 647 HIV+ patients who were 16 years old or older and who were under ART follow up from 2012 to 2017 in Debre Berhan Referral Hospital, Debre Berhan, Ethiopia. The data were from the patients' chart. All patients who have initiated to ART and measured their CD4+ cell counts at least two times, including the baseline and those who started the first line ART regimen class was included in the study population. Data were explored using basic descriptive statistics and individual and mean profile plots. The methods of LMM and GLMM were used. The mean profile of CD4+ count revealed that there is an improvement in the duration of treatment in a linear pattern. From the GLMM covariates duration of treatment, sex, BMI, baseline CD4, regimen class, duration by age, duration by baseline CD4 and duration by regimen class significantly determines the change in CD4+ count overtime at 5% level of significance. There is the duration of treatment effect on the current CD4+ count. The study result suggests that HIV+ patients attending in ART improve their CD4+ count.
机译:在ART中,CD4 +计数的测量是向AIDS演变的预测指标。研究CD4 +计数随时间变化的方式,可以洞悉疾病的进展。这项研究的主要目的是对接受ART治疗的HIV阳性患者的纵向测量的CD4 +细胞计数进行统计学分析。研究人群包括647名HIV +患者,年龄在16岁以上,并于2012年至2017年在埃塞俄比亚Debre Berhan的Debre Berhan转诊医院接受了ART随访。数据来自患者图表。所有开始接受抗逆转录病毒治疗并测量其CD4 +细胞计数至少两次的患者(包括基线患者)和开始一线抗逆转录病毒疗法课程的患者均纳入研究人群。使用基本描述性统计数据以及个人和均值图来探索数据。使用了LMM和GLMM的方法。 CD4 +计数的平均分布表明,治疗持续时间呈线性变化。根据GLMM的协变量,治疗持续时间,性别,BMI,基线CD4,治疗方案类别,年龄持续时间,基线CD4持续时间和方案类别持续时间在5%的显着性水平上显着决定了CD4 +计数随时间的变化。当前的CD4 +计数存在治疗效果的持续时间。研究结果表明,参加ART的HIV +患者可提高CD4 +计数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号